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Preface
Older persons have complex issues that influence
their quality of sleep, and there are many intriguing
issues associated with their sleep patterns. Aging is
associated with sleep fragmentation, slow waves
and fewer eye movements during REM sleep.
Typically, the aged have multiple, complex,
interacting physical and psychosocial pathology,
all of which may impact directly on their quality
of sleep. The day/night reversal of sleep and
wakefulness, the incidences of confusion that
can occur at twilight (“sundowning”), and the
nocturnal delirium in persons suffering with
dementia can be catastrophic.
While we do not fully understand its myriad
functions, we know that sleep is both restorative
and protective. We need more investments in
research on sleep and its disturbances.
Robert N. Butler, M.D.
President and CEO
International Longevity Center-USA
I
n 1975 when the National Institute on Aging
(NIA) was founded, research on sleep was
given low priority by its parent organization
at the National Institutes of Health. But
because sleep problems are so common among
older persons and the topic so neglected, the
NIA conducted a workshop to stimulate research
on this important topic. Over the years the field
has gained momentum, attracting the attention 
of the scientific community and the public, and
gaining financial support.
Quality of sleep is tied to quality of life and,
indeed, to the genesis of disease. Sleep may play 
a salient role in increasing vulnerability to illness
and disability. For example, sleep deprivation 
produces a prediabetic state, and evidence suggests
that sleep is important in the maintenance of
immune function.
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both shallow and decreased in total amount.
Decreases in slow-wave sleep begins in midlife,
whereas decreases in REM sleep and increased
sleep fragmentation grow more common during
late life. These changes in sleep quality and
specific sleep stages are accompanied by an 
alteration in hormonal and metabolic profiles
that may negatively affect health outcomes 
in aging.
Future research needs include the following:
• Longitudinal studies to confirm a causal role
of mild-moderate sleep disordered breathing
in cardiovascular and behavioral morbidity.
• Understanding the natural history of sleep 
disordered breathing with aging.
• Community trials in weight loss and exercise 
to decrease sleep disordered breathing.
• Recognition of sleep disordered breathing as a
significant public health problem in federal and
other prominent health initiatives.
• Continuation of existing educational programs
and new conduits for public education initiated
to inform the public of the role of overweight 
in sleep disordered breathing.
• Goals for the reduction of sleep disordered
breathing via weight loss and exercise.
• Research on the relationship between sleep,
cognition, aging, and neurophysiological 
mechanisms.
• Education programs at all levels of society 
that address the importance of adequate 
sleep in terms of brain functioning and 
physical health.
I
nsomnia is a common complaint in older
adults, and, although occasional sleep 
complaints may not be associated with age,
chronic sleep difficulties are experienced
more often by older adults than by younger
adults. The development of new sleep difficulties
is associated with poor health or psychological
factors, and untreated insomnia is liked to poor
health and may be associated with increased
morbidity and mortality risk. Chronic insomnia
can have a serious impact on daily functioning
and can result in reduced quality 
of life in older adults.
Some of the main factors contributing to insomnia
in older persons are medical and psychiatric illness,
medication use, circadian rhythm disorders, and
primary sleep disorders. Resolving sleep difficulties,
no matter what the cause, is related to better
health quality. The most consistent changes in
sleep associated with aging are earlier sleep
onsets, earlier morning awakening, decreased
amounts of deep or slow-wave sleep, and an
increase in the number of awakenings.
Several factors have been implicated to produce
sleep fragmentation in older persons, including
fundamental age-related alterations in the 
neurobiology of circadian rhythms and sleep;
environmental, behavioral, and social factors,
low levels of physical activity, and lack of exposure
to bright light; sleep disorders such as sleep
apnea, restless legs syndrome, and periodic 
limb movement disorders; and chronic medical 
and psychiatric disorders.
There are prominent age-related changes in
sleep homeostatic regulation. While older adults
spend more total time in bed, nocturnal sleep is
Executive Summary
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To address these problems, a small consensus 
workshop of leading researchers on sleep and aging
convened to review and evaluate current data on:
• Good sleep as part of a healthy lifestyle
throughout life
• Sleep problems in midlife and in older adults
• Treatments and interventions for improving
sleep throughout life
These discussions led to the identification of
research opportunities and the need for public
and professional education.
S
leep problems are among the most 
common health-related complaints of
older persons (defined here as individuals
aged 50 and above), but frequently
physicians are not trained to recognize sleep 
disorders in this population or they assume 
that sleep disorders are an inevitable part of
aging. Yet even physicians who correctly 
diagnose sleep disorders may not be able to
offer treatments because of a paucity of effective
therapies. More precisely, not enough research 
has been done on the causes of sleep disorders
and effective therapies.
The Purpose of This Report
1INTRODUCTION
More than half of all people aged 65 and older
experience sleep problems. Insomnia affects
approximately one-third of older Americans1 and
can result in excessive daytime sleepiness, attention
and memory problems, depressed mood, falls, and
a lower quality of life.2-8 Other factors associated
with aging may also contribute to sleep problems.
These include disease, changes in environment,
or concurrent age-related processes. However,
the old dogma that poor sleep is a natural part 
of aging has been disproved. Data indicate that
age itself does not predict insomnia, even in the
presence of a decrease in sleep efficiency and
decreased proportion of slow-wave sleep. Rather,
the prevalence of insomnia and other sleep 
disorders is high in the population due to a 
variety of factors common in late life.9-12
SLEEP DISORDERED BREATHING
Defining sleep disordered breathing
Sleep disordered breathing encompasses the 
following:
• Obstructive sleep apnea (recurrent interruptions
of breathing during sleep)
• Hypopnea (shallow breaths during sleep)
• Upper airway resistance syndrome 
People with obstructive sleep apnea have frequent
and repetitive episodes of oxygen deficiency,
experiencing momentary awakenings that result in
sleep deprivation. The clinical symptoms include
loud snoring and excessive daytime sleepiness. The
intermittent abnormal deficiency of oxygen in the
arterial blood (a condition known as hypoxemia),
and episodes of brain activation (known as arousal
states) are associated with abrupt increases in
systemic blood pressure. Some studies suggest 
that patients with sleep disordered breathing do
not demonstrate the expected nocturnal dip in
blood pressure.13-15
Using a definition of sleep disordered breathing as
the occurrence of five or more breathing pauses per
hour of sleep, estimates from the Wisconsin Sleep
Cohort Study (WSC) suggest that 9 percent of
women and 24 percent of men have some degree
of undiagnosed sleep disordered breathing, and
that 2 percent of women and 4 percent of men
meet clinical guidelines for treatment.16 These data
are essentially the same as those found in a study 
in Pennsylvania, which showed a prevalence of
clinically defined sleep apnea of 1.2 percent in
women and 3.9 percent in men over the age range
of 20 to 100 with mean age 48.8.17
Diagnosis is confirmed by polysomnography,
which identifies apnea and hypopnea events.
Severity can be expressed by the number of 
respiratory events per hour (also referred to as
the apnea-hypopnea index). Clinically defined
sleep apnea is generally determined by greater than
15 events per hour, depending on other symptoms,
including daytime sleepiness.
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2Risk factors for sleep disordered breathing
1. Weight: The most important risk factor for
sleep-disordered breathing is the presence of
overweight or obesity. A recent prospective study
from the WSC documented the role of weight
gain in increasing incidence and progression of
sleep disordered breathing, and weight loss in
slowing its progression.15 This study is important
because it demonstrates that even modest weight
loss can have a positive effect.
2. Alzheimer’s disease: APOE-4, a genetic risk
factor for Alzheimer’s disease, was reported to be
significantly associated with sleep apnea in a sample
of adults ages 30 to 60 years in the Wisconsin
longitudinal cohort sleep study.18 Such an 
association between sleep disordered breathing
and APOE-4 was not found in a much older
(ages 79 to 97) Japanese-American cohort,4 most
likely reflecting differences in age, ethnic, and
body mass index (BMI) factors. (BMI is a method
of determining caloric nutritional status. It is
measured as weight in kilograms divided by height
in meters squared.) However, these findings support
further studies on common genetic factors between
sleep disturbances and cognitive decline.
Effects of sleep disordered breathing
The breathing pauses of sleep disordered breathing
cause acute cardiovascular abnormalities. Apnea
and episodes of hypopnea during sleep cause
acute temporary changes in blood pressure,
inducing elevations in mean arterial pressure (of 
30 mmHg or more); fluctuations in heart rate and
rhythm; increased sympathetic nerve activity;
arousal and sleep fragmentation; and swings in
pressure within the cavity of the chest.
Prospective data from the WSC15 and 
cross-sectional data from several other studies
support a role of sleep disordered breathing 
in hypertension. Several clinic-based studies 
and a cross-sectional analysis of self-reported 
cardiovascular disease in the Sleep Heart Health
Study support a significant association between
sleep disordered breathing and cardiovascular 
disease.19 (Cross-sectional analysis involves a 
one-time study of a disease by its state and 
distribution in a population.) Additional analyses
examining this association along the entire spectrum
of sleep disordered breathing severity suggested that
most of the elevation in risk of cerebrovascular
disease occurs as the apnea-hypopnea index rises
from 0 to 10 events per hour.
Sleep disordered breathing has been linked to
considerable behavioral abnormalities, including
excessive daytime sleepiness, decreased cognitive
function, depression, as well as motor vehicle
accidents and decreased quality of life.16 Excessive
daytime sleepiness is a cardinal feature of clinically
recognized sleep disordered breathing.20
Several studies of sleep apnea patients have
linked sleep apnea to high motor vehicle crash
rates and poor performance on driving simulators.20
Similar findings were reported in a population
study of the WSC of undiagnosed sleep disordered
breathing and state accident records.
New data from the WSC show a significant
association of sleep disordered breathing with
depression, a major cause of health care utilization.21
Using the Zung depression inventory to measure
depression, people with an apnea-hypopnea
index greater than five, compared to those with
no sleep-disordered breathing, had three times
the odds of prevalent depression.
What can be done to reduce the incidence and
associated morbidity of sleep disordered breathing?
a) Increased identification and treatment of 
undiagnosed sleep disordered breathing using
case-finding based on primary care or population
screening, and 
b) Population-based interventions to prevent 
the development or halt the progression of sleep
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disordered breathing. The high prevalence 
of sleep disordered breathing, particularly 
at the milder end of the spectrum however,
raises several issues in that the effectiveness 
of case findings is hampered by the lack of 
adequate clinical resources to meet even current
demands. Problems with patient acceptance of 
the available treatment modalities and uncertainty
regarding the benefits from treatment of mild or
asymptomatic sleep disordered breathing further
hamper treatment.
Snoring is a strong marker for sleep apnea and
upper airway resistance. Snoring without frank
apnea and hypopnea events (simple snoring) is
often considered to be at the mildest end of the
sleep disordered breathing spectrum and is likely to
progress. Snoring is not benign. The Nurses Health
Study found that snoring was positively associated
with the development of new hypertension,
cardiovascular disease, and diabetes. Potentially
modifiable risk factors for sleep-disordered
breathing are overweight and obesity, alcohol,
smoking, nasal congestion, and estrogen depletion
in menopause.
Recent data suggest that sleep disordered breathing
is associated with all of these factors, but at present
weight loss is the only intervention strategy
supported with adequate evidence. Interventions,
such as exercise programs in conjunction with
dietary control, to reduce overweight and obesity
through both population and clinic-based programs
hold the greatest promise for reducing the burden
of mild sleep disordered breathing.
SLEEP DEPRIVATION
The metabolic syndrome
The metabolic syndrome is defined as a clustering
of three or more of the following risk factors in an
individual: abdominal obesity, elevated triglycerides,
low level of high-density lipoprotein cholesterol,
high blood pressure, and high serum glucose.
People with the metabolic syndrome are at
increased risk for developing diabetes mellitus
(type 2 diabetes) and cardiovascular diseases.
Insulin-resistance is the diminished effectiveness 
of insulin in lowering plasma glucose levels.
Emerging data implicate sleep apnea as a risk 
factor for indicators of diabetes such as insulin-
resistance and impaired glucose tolerance. In
addition, sleep deprivation and sleep apnea 
may activate the sympathetic nervous system
(which reduces digestive secretions, speeds up
the heart, and contracts blood vessels) and activate
proinflammatory cytokines, with impact on the
cardiovascular system.22,16 Moreover, sleep disordered
breathing may be linked to abnormal lipid
metabolism. Thus, sleep disordered breathing
and sleep deprivation may play a significant
role in the metabolic syndrome.
Using the 2002 census data, the third National
Health and Nutrition Examination Survey
(NHANES), it was estimated that 24 percent of 
U.S. residents (47 million) have the metabolic
syndrome.23 It also is associated with obesity,
which is defined as a BMI greater than 30.
Reports on increasing trends for obesity in the
United States show that the greatest prevalence
(35.8 percent and 39.6 percent for men and
women, respectively) and increase (12.0 percent
and 11.0 percent for men and women, respectively)
in the NHANES of 1999 to 2000 is in the 60 to
74 age groups.24
However, sleep disordered breathing independent
of obesity also is associated with the metabolic 
syndrome, with studies showing that middle-aged
men with sleep apnea, when compared to age- and
BMI-matched nonapnea controls, were found to
have higher levels of plasma leptin, TNFa, and 
IL-6 (indicators of a fundamental pathologic
process, they are referred to as “inflammatory
markers”), and increased insulin-resistance indices
(fasting plasma glucose and insulin).25-26
4ILC Workshop Report: Sleep, Health, and Aging
A study of data from healthy men, aged 16 to 83
years, looked at 24-hour profiles of plasma growth
hormone and the stress hormone cortisol, and
sleep using polysomnography sleep recordings.
(Polysomnographs measure brain activity,
movements, and breathing during sleep.10) It was
found that the decrease in slow-wave sleep, i.e.,
the deepest, most recuperative stage of sleep, from
early adulthood to later life was paralleled by a
decrease in growth hormone secretion.
Association of sleep with cortisol concentrations,
on the other hand, were independent of age and
became significant only after age 50 when sleep
became more fragmented and rapid eye movement
(REM) sleep, i.e., the sleep that is associated with
dreaming and memory storage, declined. The strong
and robust relationships between non-REM slow-
wave sleep and growth hormone secretion have led
to the proposal that they both are under the control
of similar types of neurons that may be located in
different areas of the brain. Researchers have shown
that drugs that increase one of the functions also
increase the other. These data suggest that lifestyle
behaviors and schedules resulting in chronic sleep
restriction may increase susceptibility to metabolic
syndrome independent of sleep-disordered
breathing or other sleep disorders.
Total sleep loss in animals results in death, possibly
as a result of exhaustion of the immune system. In
humans, acute total sleep loss or severe partial sleep
deprivation, i.e., 50 percent reduction of sleep, is
associated with cumulative sleepiness and fatigue.
More recently, it was shown that one night of sleep
deprivation in young men results in a daytime
increase of inflammatory markers such as IL-6. In
this study, it was reported that those individuals
with higher amounts of slow-wave sleep were more
resistant to the effects of sleep loss on the plasma
levels of IL-6.
Sleep deprivation can also lead to changes in other
physiological systems, especially the production of
appropriate levels of hormones and proper metabolic
functioning. Studies of sleep deprivation in healthy
adults provide additional data indicating potentially
important effects on risk for insulin-resistance and
its association with obesity and hypertension.
Partial sleep deprivation of otherwise healthy control
subjects produces a level of insulin-resistance similar
to that of diabetics. Carbohydrate metabolism,
endocrine function, and gastrointestinal balance in
young, healthy adults were studied after restricting
sleep to four hours per night for six nights, as
compared to a fully rested condition obtained by
extending the bedtime period to 12 hours per
night for six nights. The state of sleep debt was
associated with decreased glucose tolerance and
insulin sensitivity, elevated evening cortisol levels,
and increased sympathetic activity. The alterations
in glucose tolerance and hypothalamo-pituitary-
adrenal function were qualitatively and quantitatively
similar to those observed in normal aging.27,9,10
While there is agreement that total sleep loss is
harmful to the health of humans, the field of
sleep research is not unanimous as to whether
small decreases in sleep have an affect on the
human brain and body. Some researchers divide
sleep into “core sleep,” which is the slow-wave
sleep, and “optional” or “buffer” sleep, which
consists of stage 2 sleep and some REM sleep.
Furthermore, recently published epidemiological
studies have suggested that insomnia, paradoxically,
is associated with prolonged life.
In a recent study that employed only modest sleep
restriction (two hours per day for seven nights),
it was shown that both young men and women
experienced increased sleepiness as measured
with multiple sleep latency test (MSLT) and
impaired psychomotor skills as measured with 
a computerized test, the Psychomotor Vigilance
Test (PVT). Furthermore, there was an increase
of the plasma levels of inflammation markers
IL-6 in both men and women, and of TNFa
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only in men. These results, combined with the
metabolic abnormalities reported in “habitual”
short sleepers, suggest that even modest sleep loss
is associated with a low-grade inflammation and
insulin-resistance. Given the association between
inflammation, insulin-resistance, obesity, diabetes,
and cardiovascular morbidity, i.e., hypertension
and ischemic attacks, one can speculate that even
modest sleep loss, on a chronic basis, jeopardizes
the health and longevity of older individuals.
Sleep homeostasis
The sleep-wake cycle appears to be controlled by
two processes:
1) A circadian drive for wakefulness located in the
suprachiasmatic nuclei (SCN) of the hypothalamus
(the SCN is the biological clock that controls the
circadian patterning of many neural, endocrine,
and behavioral functions), and 
2) A wake-dependent increase in sleep propensity
probably situated within the classical pontine and
thalamic sleep system, and more recently found
within the hypothalamic preoptic area.
The SCN is the biological clock that controls the
circadian patterning of many neural, endocrine,
and behavioral functions. Although there is a
growing body of research on the aging circadian
system, relatively little exists on the aging sleep
homeostatic mechanisms.
In older people, there is a reduced ability to fully
and rapidly recover from prolonged wakefulness.
During recovery from the stress of prolonged
wakefulness, the sleep has less slow-wave sleep
and is of shorter duration than in younger adults,
as was found in several studies comparing sleep 
in young and old rats.28-29
Midlife is associated with an increased prevalence
of common sleep disorders, e.g., obstructive sleep
apnea and insomnia. The increased prevalence of
insomnia in midlife appears to some extent to be
secondary to loss of slow-wave sleep associated
with the aging process. Furthermore, insomnia
appears to be associated with hypercortisolemia
and a daytime shift of IL-6 and TNFa secretory
pattern, conditions that may lead to multiple health
problems including visceral obesity, insulin-resistance,
hypertension, and osteoporosis, which in turn, may
affect longevity.
INSOMNIA
Insomnia is a subjective complaint of insufficient
or nonrestorative sleep, which can generally be
divided into two categories, depending upon the
duration of the sleep difficulty. Insomnia may be
either short-term (transient/acute) or chronic. In
older persons, transient insomnia may be caused
by bereavement, adjustment to medical difficulties
and physical limitations. By definition, transient
insomnia is short in duration and will generally
improve without intervention or with short-term
hypnotic medication therapy. Chronic insomnia,
however, can result in impaired functioning and
reduced quality of life in older adults.30-31
Insomnia is considered to be either primary or
secondary in nature, depending upon the cause. If
an individual finds it difficult to sleep because of
pain or discomfort arising from a medical condition,
the insomnia is secondary to the primary complaint
of the illness. If no other factors exist, the insomnia
is primary. In one of the few studies done in older
adults on the effect of insomnia on quality of life,
it was found that older adults with secondary
insomnia had worse quality of life than those with
primary insomnia.32-33
In general, complaints about sleep increase 
with age, as do specific complaints of insomnia.
Estimates of the prevalence of insomnia in older
persons vary widely depending upon the way
insomnia is defined and the method of assessment
used. In one study conducted by the National
Institute on Aging on more than 6,000 older
5
adults, 28 percent reported difficulty falling
asleep, and 42 percent reported both difficulty
falling asleep and difficulty staying asleep.34 At a
three-year follow-up, 15 percent of the individuals
with sleep complaints at the initial interview did
not report sleep difficulties, and 5 percent of
those without sleep complaints at the initial interview
complained of difficulties three years later. Further
analyses of these data showed that only 5.8 percent
of individuals without risk factors for insomnia
(medical, psychosocial, or psychiatric) at the initial
visit reported insomnia at follow-up. These data
suggest that sleep complaints are generally quite
common in older adults, that developing a new
sleep problem is associated with poor health or
psychological factors, and that resolving sleep 
difficulties is related to better health quality.
The result of telephone interviews of 1,000 
randomly selected U.S. adults indicated that the
prevalence of occasional insomnia did not change
with age; however, the prevalence of chronic
insomnia was highest (20 percent) in adults age 65
and over.35 This suggests that, although occasional
sleep complaints may not be associated with age,
older adults experience chronic sleep difficulties
more often than do younger adults.
Insomnia in older adults is not benign. A number of
research studies have shown, both cross-sectionally
and longitudinally, that insomnia has a negative
impact on cognitive functioning and quality of
life.36-37,30,38,31 Insomnia patients were found to have
slower reaction time, poorer balance, and were
more likely to forget numbers in the digit span
test than carefully matched controls. Furthermore,
these deficits were seen even after the insomnia
patients spontaneously experienced a subjectively
“good night of sleep.”39
Individuals with insomnia complaints were found
to have overall poorer quality of life than individuals
without insomnia,31 and individuals with insomnia
identified more symptoms of depression and anxiety.
It is unclear whether depression and anxiety lead
to both sleep disturbance and impaired life quality,
or whether the sleep disruption leads to the impaired
quality of life and psychiatric difficulties. However,
few studies have been done on the effect of
insomnia on quality of life specifically in older
adults.37 A large epidemiological study of older adults
in the United States found that sleep difficulties
were associated with poorer self-perceived health
status. Clearly, insomnia complaints should be
carefully evaluated and treated appropriately.1,34
Before insomnia can be treated, its cause must be
determined. In addition to primary sleep disorders,
contributory factors in older persons include medical
and psychiatric illnesses, medication, and circadian
rhythm disorders. Older adults often have a number
of medical conditions that can affect and impair
sleep. Commonly, older adults complain of difficulty
sleeping in response to physical discomfort caused
by a physical ailment, such as arthritis, chronic
obstructive pulmonary disease, cerebrovascular
disease, neurological disorders, asthma, or headaches.
In fact, some studies have shown that, in the
absence of medical disorders, the sleep of older
adults is not substantially disturbed.40
Depression
Depression is the psychiatric diagnosis most
commonly associated with insomnia. Since the
prevalence of depression is higher in older than
in younger adults, sleep disturbances often are
accompanied by depression.41 Older adults with
depression have more disturbed sleep than younger
adults with depression,42 and symptoms of
depression are associated with increased likelihood
of difficulties with sleep.1
Medications
Older adults often take multiple medications for
medical and/or psychiatric problems, each of
which can have an impact on sleep. Some of the
drugs commonly used by older adults and known
to affect sleep include alcohol, central nervous
6
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system stimulants, beta-blockers, bronchodilators,
calcium channel blockers, decongestants, stimulating
antidepressants, and thyroid hormones. Drugs
known to have sedating effects include the longer
acting hypnotics, antihypertensives, antihistamines,
anxiolytics, tranquilizers, and antidepressants.
Circadian rhythm changes
With age, circadian rhythms are advanced or
shifted earlier relative to clock time. This can
result in the internally driven sleep period moving
earlier than the desired sleep period. Older adults
commonly report that they can hardly stay awake
until bedtime but are awake before the sun rises
in the morning. The fact that older adults are
likely to complain of sleep difficulties in the latter
half of the night suggests that the endogenous
timing of the sleep-wake cycle may contribute to
sleep difficulties.
Circadian melatonin rhythms
The relationship between sleep timing and 
the timing of the circadian rhythm of plasma
melatonin secretion was investigated in a group
of healthy young and older subjects without sleep
complaints.43 Timing of sleep and the phase of 
the circadian melatonin rhythm were earlier in
the older subjects although the duration of sleep
was similar. Consequently, the older subjects
awoke at a time when they had higher relative
melatonin levels, in contrast to younger subjects,
whose melatonin levels were relatively lower by
wake time. These findings indicate that aging is
associated not only with an advance of sleep
timing and the timing of circadian rhythms but
also with a change in the internal phase relationship
between the sleep-wake cycle and the output of
the circadian pacemaker.
Primary sleep disorders
Primary sleep disorders such as Periodic Limb
Movement Disorder and sleep disordered breathing
cause fragmentation of nighttime sleep. Studies
have shown that these disorders are very 
common in older adults.44-45 Oftentimes, these
individuals do not recognize the disorder itself
but rather complain of frequent nocturnal 
awakenings, sleepiness during the day, and/or
nonrestorative sleep.
Behavior-related insomnia
At times the cause of insomnia in older adults
may be behavioral in nature, such as the use of
alcohol, caffeine, nicotine, and over-the-counter
or herbal medicines, a poor sleep environment,
and excessive napping.
Therapeutic strategies
Several therapeutic strategies are likely to become
effective treatments for some of the insomnias
associated with aging. The use of bright light therapy
for phase disorders of the circadian rhythms is now
commonplace.46 Behavior modifications, such as
stimulus control and sleep restriction, appear to be
effective techniques for shortening sleep latency
and wake after sleep onset times.47
Melatonin treatment is being tested for its sleep-
inducing effects; however, it appears to be most
effective at physiological doses in dealing with
circadian dysynchrony.
A double-blind placebo-controlled clinical trial 
of melatonin was conducted on a group of 
individuals age 50 and older complaining of
insomnia and a group without insomnia.48
Self-reports of insomnia were confirmed by
measurements of body movements through the
night period at home (actigraphy) as well as by
measurements of brain activity, movements, and
breathing during sleep (polysomnography) in
the sleep laboratory.
In addition to a placebo, each participant received
different doses of melatonin (0.1, 0.3, and 3.0 mg)
orally one-half hour before usual bedtime for
one week in a random order, each followed by a
7
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one-week washout period. The highest dose (3.0 mg)
is the dose commonly found in over-the-counter
preparations and results in blood levels 10 to 20
times the normal physiological levels produced 
by the lower doses. The most effective dose for
improving the quality of sleep, measured as sleep
efficiency or the proportion of time in bed actually
sleeping, was 0.3 mg. The highest dose, like the
lowest, also improved sleep efficiency, although 
to a lesser extent. However, the 3 mg dose also
significantly reduced nighttime body temperature
and increased daytime melatonin levels.
There was no relation found between a subject’s
own endogenous melatonin levels and sleep 
efficiency. Individuals with normal sleep were
unaffected by any dose of melatonin. Further
replications with larger groups with objectively
defined sleep problems and with a broader range 
of medical co-morbidities are needed.
CHANGES IN SLEEP AND CIRCADIAN
RHYTHMS WITH AGE
Our current understanding of the regulation of
the human sleep-wake cycle indicates that sleep
and wake behaviors are generated by a complex
interaction of sleep homeostatic and endogenous
circadian processes, as well as environmental factors.
The sensation of sleepiness, propensity to fall
asleep, and depth of sleep are hallmarks of the
compensatory response to sleep loss.49 This drive
toward sleep and the tendency to sleep longer and
more deeply after sleep deprivation is referred to as
“sleep homeostatic process.” It has been postulated
that the sleep homeostatic process is regulated by
sleep factors that increase during wakefulness and
decline during sleep. Recent studies suggest
that the acetylcholine of the basal forebrain 
and adenosine may play an important role in
this physiological drive.50 The sleep homeostatic
process regulates the amount of slow-wave sleep
and depth of sleep.
Within the last several years, two important nuclei
have been identified within the hypothalamus that
are important for the control of sleep homeostasis.
The first is a cluster of cells in the ventrolateral
preoptic (VLPO) area of the hypothalamus. These
VPLO cells exhibit activation, indicated by
generation of cFos protein, (a marker protein for
activated cells), only during sleep and independent of
the circadian cycle, and are inhibited by noradrenaline,
acetylcholine, and serotonin neurotransmitters
associated with the waking state.51-52
Because the VLPO neurons are active only during
sleep, it is proposed that they are central to the
regulation of the sleep-wake cycle. Cell-specific
damage of these neurons results in significant
decreases in non-REM sleep (slow-wave sleep).
These cells interact with the systems that activate
the cortical areas that play an important role in
regulating wake-sleep states.53-55 More recently, a
gene for narcolepsy in dogs and humans has been
identified.56-57 This gene codes for a family of brain
chemical signaling agents (neuropeptides) known
as hypocretins. These neuropeptides are made only
in an area of the brain that also regulates basic
body functions such as feeding and energy balance,
blood pressures, and central regulation of the
immune system. The brain cells that contain them
make connections with many of the brain regions
involved in regulating the sleep-wake cycle. The
hypocretins may act as chemical signals involved 
in the mechanisms of homeostasis and alertness.
Gene regulation of sleep
Genes that regulate the sleep-wake cycle are being
discovered. The first mammalian Clock Gene was
identified and its structure was determined in 1994.
Using data from the WSC, one change in the DNA
code for this gene was found to be significantly
associated with preference for later sleep times,
equivalent to a 10- to 44-minute difference in
preferred timing.
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The circadian pacemaker (SCN)
Physiological sleepiness not only varies with the
duration of prior waking, but also exhibits circadian
variation. Circadian rhythms, which are observed in
virtually every physiological and behavioral parameter,
including sleep-wakefulness and endocrine rhythms,
are generated by a circadian pacemaker located in
the SCN of the hypothalamus.58-59 
At the cellular and molecular level, it has been
shown that there are age-associated changes in
afferent and efferent pathways of the SCN. It is
quite possible that disruption in the integrative
neural systems could have serious deleterious
effects in the function of other organ systems.
The circadian timing system
Sleep disturbances may also be caused in part by 
a fundamental change in the circadian timing system
of older adults.60 It has long been believed that
the human circadian clock had a period of about
25.25 hours and that it speeds up when we grow
older. This concept of the shortening of the period
with age was used to explain the common observation
that many older people went to sleep earlier in
the evening and awoke earlier in the morning.
Habitual wake time, the timing of the rise of 
hormone secretion, and endogenous temperature
rhythms of older subjects occur at an earlier clock
hour, suggesting that the earlier wake time may
be due to an advance of the circadian clock.61
These results also suggest that sleep disruption
during the last half of the sleep period might be
due to age-related increases in the phase angle
between the core temperature minimum and the
timing of sleep.46,62-63
Circadian rhythms
Age-related reductions in the amplitude of circadian
rhythms have been observed for a wide variety of clock-
regulated functions, ranging from temperature and
endocrine rhythms to cycles of subjective alertness.61,64-66
However, circadian rhythm amplitude can be well
preserved in the “super healthy” older person.67
It now appears that the intrinsic period of the
endogenous human circadian pacemaker is not 
significantly different between healthy old and
young adults and is much closer to 24 hours than
previously thought. The deterioration in the SCN
may represent a pathologic rather than a normal
change, indicating that age-related changes of
rhythm in vivo may be due to defects either
upstream or downstream from the SCN.
Age-related changes
With increasing age, prominent changes in sleep
homeostatic regulation occur. While older people
spend more total time in bed, nocturnal sleep is
both shallow and decreased in total amount.68
Polysomnographic assessment confirms the
subjective decline in sleep quality with age in
healthy older people.10 Deep sleep decreased from
18.9 percent during young adulthood (ages 16–25) 
to 3.4 percent during midlife (ages 36–50). This
decrease in slow-wave sleep was accompanied by
decreases in growth hormone levels. Surprisingly,
a further reduction in slow-wave sleep was not
seen in late life.
The impact of age REM sleep and sleep 
fragmentation was not evident until late life
(ages 71–83). During late life, REM sleep
declined gradually by approximately 10 minutes
per decade. Sleep fragmentation, as measured 
by wake time, also increased gradually, by 30
minutes per decade during late life. Interestingly,
elevation of evening cortisol levels followed the
same chronology as the decline in REM sleep.
Therefore, decreases in sleep quality may contribute
to age-related changes in metabolism that may 
predispose older people to adverse health outcomes.
In fact, the presence of disturbed sleep predicts
overall health-related quality of life better than
any other disease-activity measure in patients who
suffer from chronic illnesses.69
9
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MENOPAUSE AND SLEEP
Both sleep onset insomnia and sleep maintenance
insomnia are characteristically increased during
perimenopause and menopause. They are major
features of the medical care of women going
through menopause and should be appropriately
addressed by the physician who treats menopausal
women. In light of the Women’s Health Initiative
trials,70 the general use of estrogen replacement
has been eliminated.
Perhaps the most significant areas of research are
as follows:
• Questions regarding the relation of estrogen to
depression and insomnia remain unanswered,
and, given the prevalence of depression, this is 
a very significant public health issue.
• The basic physiology of estrogen’s effect on both
circadian rhythm and thermoregulation needs to
be elucidated, with further clarification for the
sake of future treatments that may be specific 
to the sleep effects of estrogen. Research into
selective receptor modifiers that might affect
thermoregulation, as well as studies relating to
phytoestrogens and other less potent estrogenic
substances, are needed.
SLEEP AND COGNITION
Of the many losses and diminished capacities
experienced with age, a decline in cognitive
function is perhaps the most frightening. A
number of research studies, both cross-sectional
and longitudinal, have shown that disturbed sleep
has a negative impact on cognitive functioning 
and quality of life.
A large epidemiological longitudinal study
(Honolulu-Asia Aging Study, or HAAS) of older
men (mean age of 76.6 years, range 71 to 93)
investigated the association between sleep 
disturbances (insomnia and daytime sleepiness)
and the incidence of dementia and cognitive
decline.4 It was found that there was a significant
association between the self-report of excessive
daytime sleepiness, found in 8 percent of the cohort,
and a diagnosis of dementia three years later.
The risk was twofold (O.R. = 2.2) as compared 
to those not reporting daytime sleepiness, after
adjusting for age and other factors. Cognitive
decline also was significantly associated with excessive
daytime sleepiness (O.R. = 1.4). In contrast,
insomnia, found in 31 percent of the cohort, was not
associated with either cognitive decline or dementia.
Memory
Recent research on the importance of sleep for
the consolidation of memory suggests that different
stages of sleep may facilitate the consolidation of
different memory tasks. For example, post-training
REM sleep may be important for procedural
memory, and non-REM slow-wave sleep may be
important for declarative memory.71 However,
there are contradictory findings in the literature.
A possible role for the importance of REM sleep
rather than slow-wave sleep in humans has been
suggested.72 Interestingly, the beneficial effect of
REM sleep on memory consolidation appears to
parallel the beneficial cognitive effects of cholinergic
medications that increase REM sleep. It should
be noted that human sleep and memory studies
have demonstrated that memory consolidation
can take place during sleep. This does not mean
that sleep has a unique role not found in quiet
wakefulness.
One possible exception is that in an experiment
using a perceptual learning task, Stickgold et al.
found that performance improved only after a
night of sleep.73 For a visual texture discrimination
task, consolidation of learning required more than
six hours of sleep on the night following training.
Slow-wave sleep appeared necessary during the
first two hours of sleep and REM sleep after the
sixth hour of sleep. When subjects were totally
sleep-deprived the night after training, no
10
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improvement was seen even after two nights of
recovery sleep. These data suggest an important
role for human sleep in off-line (nonwaking)
memory reprocessing. However, subjects tested
after different periods of wakefulness were not kept
in controlled conditions, such as quiet wakefulness
or without visual stimulation. Thus, it is not clear
whether sleep facilitated improved performance or
waking experiences prevented improvement.
A study done on kittens demonstrated that sleep
facilitates neural reorganization as a result of altered
experience.74 Kittens that had one eye sutured for 
24 hours showed more neural accommodation to
monocular visual experience following sleep than
following waking experiences in either a lighted or
darkened environment. Thus sleep, and not the lack
of visual experience, facilitated neural plasticity for
visual processing. There has not yet been a similar
demonstration for memory.
Both hyperarousal and central nervous system
depression are associated with deficits in cognitive
functioning, whereas moderate levels of arousal
are often associated with improved functioning.
Variation in cognitive functioning related to circadian
rhythms, sleep deprivation, and sleep disorders such
as insomnia and sleep apnea can be understood
within this broad framework.
For example, there is a strong circadian arousal
effect on memory performance in which older
human adults perform better in the morning than
in late afternoon. This late afternoon deficit can
be eliminated by caffeine,75 suggesting that some
of the deficit, at least, is mediated by physiological
arousal. Parenthetically, insomniacs, who are often
hyperaroused, show more evidence of continued
cognitive processing in sleep than good sleepers.76
With regard to sleep deprivation and the resulting
daytime sleepiness, many studies have shown that
the speed of performance slows and that there are
lapses in attention. There are relatively few deficits
in accuracy in executive functioning tasks during
even severe sleep deprivation. This is in contrast
to marked sleep inertia effects on cognition when
subjects are awakened out of slow-wave sleep
after being sleep-deprived.77 
Cognitive deficits and sleep apnea
There is a large and increasing research literature
on the cognitive deficits associated with sleep apnea.
A summary of the results from different research
designs can serve as a good model for other areas.
There are five broad types of research designs:
1) Cross-sectional studies comparing sleep apnea
patients to nonpatients have found that sleep
apnea impairs attention, short-term memory,
perceptual learning, acquisition in long-term
memory, and categorization;
2) Studies examining whether oxygen deficit or
sleep disruption are most associated with deficits
have found that most cognitive deficits are associated
with hypoxemia, although attention deficits are
also associated with disrupted sleep;
3) Studies examining whether nasal continuous
positive air-pressure (nCPAP) reverses cognitive
deficits found that many deficits are reversed, but
only on nights on which nCPAP is used; some
deficits reflecting executive functions do not
reverse32 (nCPAP is a device that provides a 
continuous flow of oxygen to the sleeper);
4) Cross-sectional studies of normal populations
have typically found small or no relationship
between sleep disordered breathing and cognitive
functioning. In a Sleep Heart Health Study
cognitive substudy in which participants were
generally older adults and a substantial portion of
the sample had disordered breathing, deficits in
attention, manual dexterity, psychomotor efficiency,
and executive functioning were found;78 and
5) Longitudinal studies of normal populations
have not found predictive effects of baseline
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disordered breathing with cognitive functioning
on subsequent measurement occasions; but similar
to the cross-sectional studies of normal populations,
the proportion of individuals with sleep disordered
breathing is either small or the severity is low.
Memory at the molecular level
Research at the molecular level is examining the
molecular processes underlying the role of sleep 
in the consolidation of long-term memory using
specific phosphorylated cyclic AMP-responsive
element binding protein (CREB)-mutant mice.79
Results indicate that like sleep deprivation,
inhibition of protein kinase A (PKA) or protein
synthesis disrupts memory consolidation only 
at discrete times following training, and these
times vary depending upon the strength of the
training protocol.
This is an exciting window of opportunity 
as research on the relationships between sleep,
cognition, aging, and neurophysiological 
mechanisms is just beginning to coalesce.
HOW OLDER PERSONS ARE TREATED 
FOR SLEEP DISORDERS
The interrelationships between sleep and health
are crucial, particularly for older individuals.
The degree to which declining physical and
mental health impacts sleep quality in the aged
population was for many years an under-appreciated
phenomenon. The earliest epidemiological studies
of sleep complaints typically reported that they
were more common in women and increased with
age, with some studies finding prevalences as high
as 40 percent to 50 percent in the older population.
Further studies confirmed these basic findings.
However, a wave of epidemiological studies published
in the late 1980s began to demonstrate that when
other potential causes of disturbed sleep are
accounted for, such as medical or psychological
burden, chronological age often explained little of
the observed prevalence of age-associated poor
sleep quality.80
Two observations come readily from these 
epidemiological data. The first is that fully half 
of the population of older persons do not report
disturbed sleep or at least are content with the
sleep that they achieve. The second is that much,
if not all, of the sleep complaints that are seen
with advancing age are apparently not part of the
aging process per se, but are associated with other
factors such as medical burden, which itself tends
to increase with advancing age.
Regarding this first observation, while approximately
half do not complain of poor sleep, numerous
studies have shown that even optimally aging,
noncomplaining older adults have sleep patterns
that are considerably “degraded” from those seen
in healthy young adults.80-82 This finding is consistent
with the more recent epidemiological literature
indicating that while aging, per se, results in
significant changes in sleep, it does not of necessity
result in complaints of disturbed sleep or insomnia.
It has been suggested83 that, despite their objectively
disturbed sleep, healthy older individuals appear
to adapt their perception of what is “acceptable”
sleep and therefore do not necessarily complain.
The second observation that all of the sleep
complaints that are seen with advancing age are
not part of the aging process per se, but rather
are associated with other factors such as medical
burden, has been followed up by opportunistic
studies80 that demonstrated that screening large
samples of older adults for health before screening
for sleep disturbance and sleep disorders left
very few subjects who had a significant sleep
complaint or disorder. In other words, poor
health and sleep disorders co-segregate.
Recently the NIA-funded Established
Populations for Epidemiologic Studies of the
Elderly (EPESE) examined this apparent 
relationship between sleep complaints and
physical and mental health across a three-year
window in some 6000+ subjects. Data from the
12
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EPESE study have demonstrated that development
of a complaint of insomnia is commonly associated
with an emergent medical or psychological co-
morbidity.1 Further, EPESE data also indicated
that resolution of a complaint of insomnia is
commonly associated with contemporaneous
resolution of a medical illness.84
The major implication of the secondary nature of
many sleep disturbances reported by older persons
has led to the current clinical wisdom of “treat the
primary problem effectively and the secondary,
or symptomatic, sleep disturbance will likely
resolve.” This is not an unreasonable and functional
approach, but it may be far from the best clinical
practice. A multimodal cognitive-behavioral
approach to primary insomnia has recently been
demonstrated to be so effective in treating primary
insomnia85-87 that it has been provisionally extended
to include secondary or co-morbid insomnia.
Rybarczyk and colleagues at Rush-Presbyterian in
Chicago are currently comparing the efficacy of
cognitive-behavioral and relaxation treatments
versus an attention control (wellness/stress class)
for treatment of insomnia among patients with
three common age-related chronic illnesses:
osteoarthritis, chronic obstructive pulmonary
disease, and coronary artery disease with exceptionally
high rates of co-morbid insomnia. Clearly, other
well-designed and controlled studies such as
Rybarczyk’s88 will be needed to address this
extremely important question.
Much has been made of the observation that
there may be two kinds of apnea that manifest
themselves in the late middle-aged to older segments
of the population. One is age-related and is associated
with significant daytime sequelae that seems to
impact individuals as they age from their 40s to
70s and then gradually drops as these individuals
die (typically of apnea-related disorders, such as
coronary artery disease, stroke, etc.). The other is
an age-dependent disorder that begins to impact
individuals in their 60s, increases in prevalence
across the rest of the life-span, and is not necessarily
associated with significant daytime sequelae.89-92
A crucial question facing both researchers and
practitioners of sleep medicine is whether to treat
age-dependent sleep apnea, particularly in the
absence of any significant daytime sequelae. This
question is of great concern, as it is closely interwoven
with the related question of whether sleep apnea
contributes to cognitive impairment and ultimately
Alzheimer’s disease in older persons.93-94
Periodic limb movement disorder
There is considerable controversy concerning
whether periodic limb movement disorder (PLMD)
is a true disorder, that is, whether or not it is a
clinical symptom resulting in sleep disturbance or
significant insomnia. A body of literature exists95-100
indicating that there is little reason to support the
notion that PLMD is a true disorder as there is little
relationship noted between the presence of PLMs
and either sleep fragmentation or daytime sequelae.
This is of concern as PLMs are quite frequent in
older persons.
Treating institutionalized and/or demented aged
All of the issues confronting the practitioner in
effectively treating sleep disturbances in cognitively
intact, community-dwelling older patients are
magnified in the treatment of sleep disturbances
in older patients who are demented, institutionalized,
or both. The current state-of-the-art in effectively
treating sleep disturbances in the demented and
the complexities of treating sleep disturbances in
the institutionalized aged have been comprehensively
reviewed.101-104 Following is a proposed research
agenda105 to further study the field:
• Longitudinal changes in sleep during the course
of dementia.
• Randomized controlled trials of treatments for
behavioral disturbances using measures of sleep, day-
time function, and impact on caregivers in addition
to behavioral and psychiatric outcome measures.
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• Randomized controlled trials to assess 
comparative efficacy of specific pharmacological
and nonpharmacological approaches to sleep
management.
• Long-term efficacy and safety of newer hypnotic
agents in demented patients with sustained
sleep disorders.
• Studies targeted at a better understanding of 
the impact of improved sleep quality on the 
cognitive function of demented patients.
• Empirical validation of algorithms for assessing
and managing sleep in dementia.
• Controlled health services trials of effect of changes
in institutional policies on residents’ sleep.
Hypnotics
Approximately one-half of all patients who complain
to their physicians of insomnia are treated with
hypnotics. Although these drugs may be useful 
in the management of transient insomnia, they
generally fail to provide long-term relief from
chronic sleep disturbances. Prolonged use can
result in habituation, loss of efficacy, and drug-
induced insomnia. Paradoxically, hypnotics can
worsen existing sleep disturbances by inducing
drug-dependency insomnia, and, when the drug is
discontinued after intermediate to long-term use,
rebound insomnia and nightmares may occur.
Hypnotics may also exacerbate undiagnosed
sleep apnea.
Adverse daytime effects of hypnotics include impaired
cognition, slowed psychomotor functioning, and
injuries induced by falls. Chronic hypnotic use
also has been associated with increased mortality
risk. Two NIH consensus conferences have endorsed
the cautious use of hypnotics for temporary,
situational, or intermittent conditions (such as
stress-related sleep disturbance), but otherwise
strongly recommended against their use for
other conditions, such as chronic insomnia.
Nevertheless there is considerable disagreement
in the sleep research and sleep medicine communities
with regard to chronic use.106-111 The single point of
agreement between these often contentious points 
of view is the need for appropriately designed and
executed long-term randomized trials. The vast
majority of past hypnotic trials have been of relatively
short duration, typically under two to three months.
Adding to the complexity of the pharmacotherapeutic
picture are the issues of alternative therapeutic
agents such as melatonin and valerian, both of
which have extremely limited data to support
their effectiveness as sleep aids, and the emerging
research efforts exploring the efficacy of agents
that may have their actions via the somatotrophic
hormonal axis112-113,103 or the related gabaergic
system114 to improve the sleep quality of older 
persons. (Somatotropin is a protein hormone that
promotes body growth, fat mobilization and
inhibition of glucose utilization. The gabaergic
system, of which GABA is the key component,
is involved in the inhibitory mechanisms of the
central nervous system.)
Exercise and sleep
There is considerable evidence to substantiate
claims of the beneficial effect of regular exercise—
both endurance (aerobic) and resistance (weight)
training—on health and quality of life in older
individuals.115-117 Regular exercise is linked to a
number of positive outcomes, such as increased
aerobic capacity, increased strength, improved
body composition (increased lean and decreased
fat mass), improved balance and decreased risk of
falls, decreased depressive symptoms, increased
functional capacity and improved sense of energy
and general well-being. Regular exercise may also
be associated with improved immune function,
although there are only limited data in support 
of this relationship. Regular exercise has been
demonstrated to lower risk for a number of 
diseases, including hypertension, stroke, coronary
14
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artery disease, hyperinsulinemia, insulin-resistance
and non-insulin-dependent diabetes mellitus, and
disease-related mortality.
Epidemiological studies consistently support the
view that acute and chronic exercise promotes
sleep.118 A large (n = 1190) Finnish study found
that, in response to open-ended questions, both
men and women reported exercise as the most
important sleep-promoting factor, and respondents
who reported getting regular exercise had less
daytime sleepiness compared to those who were
more sedentary. It is noteworthy that 43 percent
of those who reported increased amounts of exercise
during the previous three months (n = 81) reported
improved subjective sleep, compared with only 
1 percent, whose self-reported sleep deteriorated.
Conversely, 30 percent of those subjects who
reported decreased exercise in the previous three
months (n = 73) reported deterioration in their
sleep, compared to the 4 percent who reported
improved sleep quality.
Epidemiological data clearly support the hypothesis
that regular exercise is associated with improved
sleep quality.119-121,33 However, at this time there 
are no published randomized controlled trials
examining the influence of exercise on the
objectively measured sleep of older individuals
either complaining of sleep disturbance or of
older insomniacs, and no randomized controlled
trials of impact of exercise on the subjective sleep
of insomniacs. Such studies will be required before
we can clearly delineate the beneficial effect of 
regular exercise on sleep quality in older individuals
and the long-term impact of such improved sleep
on health, longevity, and quality of life.
Naps in older persons
Daytime sleepiness among older persons occurs
less frequently than does insomnia. However,
sleepiness and napping both increase with age;
daytime sleepiness has a prevalence of approximately
15 percent to 40 percent in older persons122-125
compared with a lower prevalence of approximately
7 percent to 15 percent in the general adult
population.126-128 Daytime sleepiness has been
related to a number of psychological and physical
variables; sleepiness is related to snoring, sleep
apnea, medications, poor general health, and
depression. Daytime sleepiness is more frequent
in older men than women.
The distinction between daytime sleepiness and
napping is not precise. However, several studies
have examined the occurrence of napping, as
opposed to the symptom of daytime sleepiness.
Such studies indicate that the frequency of napping
also increases with age.129-133 However, these
studies report widely variable prevalence figures
for napping, which likely are related to factors
such as cultural influences, differences in age,
health, and employment status of subjects, and
different methods for determining the presence 
of napping. Although sex differences in napping
have not been consistently reported, studies that
show differences find that men report more 
frequent napping than women.1,123
It is unclear whether daytime napping and even
daytime sleepiness represent voluntary, optional
behaviors or an involuntary expression of
pathological sleepiness. In trying to address 
this issue, some studies have reported a positive
association between daytime sleepiness and
insomnia complaints122-123 or a positive correlation
between the frequency of naps and middle-of-
night awakenings.131-132 However, other studies
show no relationship between naps and nocturnal
sleep,133-134 and still others note a positive correlation
between naps and nocturnal sleep length for a
24-hour sleep duration.123,105,131
Two studies have experimentally investigated 
the relationships between daytime napping and
performance and nighttime sleep. One showed an
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increase in total 24-hour sleep time among those
who napped, but polysomnographic studies showed
a reduction in nocturnal sleep time during napping
as well as a reduction in nighttime sleep efficiency.
(Polysomnographic studies continuously monitor
normal and abnormal physiologic activity during
sleep.) Evening alertness was improved among
nappers. No changes were noted in circadian rhythm
measures or performance.135 A similar study136 showed
that afternoon performance and subjective sleepiness
and fatigue were both improved, suggesting that brief
naps may have a positive but short-acting effect.
As noted above, cross-sectional epidemiologic
studies have shown that daytime sleepiness is
associated with worse health. Recent data from
large cohort and epidemiologic longitudinal
studies137-139 suggest that daytime sleepiness can also
be associated with adverse health consequences. It
is unclear whether sleepiness and napping per se
increase morbidity and mortality. A more likely
explanation is that sleepiness is attributable to
some other health factor, which also leads to
adverse health outcomes. Thus, daytime sleepiness
may be an early indicator of subclinical as well
as clinically evident medical illness. It should also
be noted that other studies have failed to find an
association between daytime sleepiness/napping
and mortality.140
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FUTURE DIRECTIONS AND RECOMMENDATIONS
• Longitudinal studies are needed to confirm a causal
role of mild-moderate sleep disordered breathing in
cardiovascular and behavioral morbidity in order to
fully determine the cost of morbidity attributable to
sleep disordered breathing.
• Understanding the natural history of sleep 
disordered breathing with aging is crucial.
• Community trials in weight loss and exercise to
decrease sleep disordered breathing severity and
occurrence are desperately needed.
• Recognition of sleep disordered breathing as a
significant public health problem in federal and
other prominent health initiatives is needed;
programs targeting obesity in children should
identify sleep disordered breathing as one of the
important negative health outcomes.
• Existing educational programs (National
Institutes of Health and the National Sleep
Foundation) should continue, and new conduits
for public education should be initiated, to
inform the public of sleep disordered breathing;
in particular, of the role of overweight in sleep
disordered breathing.
• Goals for the reduction of sleep disordered
breathing via weight loss and exercise should be
set; a surveillance system to document trends in
sleep disordered breathing should be established.
• The findings that there appear to be distinct
changes in sleep quality that occur through the
adult age span that also mark specific alterations
in hormonal systems that are essential for metabolic
regulation need to be pursued.
• Research on the relationship between sleep,
cognition, aging, and neurophysiological 
mechanisms is an exciting area that needs 
further development.
The importance of adequate and regular sleep, along
with weight management, healthy eating habits, and
regular exercise, should be part of public education
and policy. These measures may include:
• Education of young and middle-aged individuals 
of the importance of adequate sleep in terms of
brain functioning and physical health.
• Explanation of the association of sleep 
loss/disturbance to obesity and its sequelae.
• Education of middle-aged individuals about the
association of stress and sleep disturbance and
the need for better coping mechanisms to
reduce stress.
• Education of employers and public policymakers
on the association between sleep loss/irregular
sleep, e.g., shift work, and the public safety and
health of employees.
• Education of physicians and health professionals on
the importance of early detection and intervention
of common sleep disorders, e.g., sleep apnea,
insomnia in middle-aged individuals.
• Future research needs include the delineation 
of the needs versus the ability to sleep in older
adults, and establishing the effects of insomnia
upon the quality of life.
ILC Workshop Report: Sleep, Health, and Aging
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